Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles

CStone Reports Positive Results from Phase III Lung Cancer Trial of Immunotherapy
NeuPharma Starts Phase II Trial of Novel Treatment for Glioblastoma Multiforme
Biogen Enters $2 Billion Deal to Co-Develop Parkinson's Candidate in US and China
Lepu Biotech Closes $186 Million B Round for Cancer Immunotherapies
VistaGen Receives $5 Million Upfront Fee from EverInsight for SAD Therapy
Upcoming event
August 25-27, 2020
China Standard Time
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China